P61704 AF NFT

Alanine--tRNA ligase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeig3ixsvyo6g7whiftdqgzuiaujt55mbf23t7l4yfamkyv4fwxmprq/metadata.json
IPFS of structure file: 
bafybeicyyrty7yvgezlsm2p7na4rfl53xytktwhp53ibelmr7ylgvgy4va/AF-P61704-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xF3fCF73A57fF07812365d50F6f04BD3B60f3c2f2
First NFT owner address (bech32): 
genesis17070wwjhlurczgm9658k7p9a8ds08shjalwpcd
Current NFT ID #443220 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
443220
Accession (UniProt):
P61704
Name::
Alanine--tRNA ligase
Experimental Method:
Predicted structure
Sequence source:
Mycoplasma mycoides subsp. mycoides SC (strain PG1)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT P61704 research and analysis (ICN3D with VR)

FASTA sequences

>sp|P61704|SYA_MYCMS Alanine--tRNA ligase OS=Mycoplasma mycoides subsp. mycoides SC (strain PG1) OX=272632 GN=alaS PE=3 SV=1 MKKLSTNQIRKIWLDFFISKNHYFLETVSLIPVDDPSLLWINSGVATLKPYFDGRKTPPSPRLTNSQKAIRTNDIENVGVTARHHTMFEMLGNFSIGDYFKKEAIELAWELLTDKKYFDIDKNKLYITVFNEDTEAYNIWKDVIKIDEDHIFRLSRKTNFWDVGQGPCGPNTEIFYDRGEIWDPNKIGPRLISDDIENDRYIEVWNIVFSQFNNDGNNNYVELPRKNIDTGAGLERFASIFQNTPTNFETDIFYPTIKKVEQLTNNQFKYSIDNYFNPNKKQTRINTAFKVIADHIRATVFAISDGVFPGNKDRGYIIRRLIRRSCVFGKELGIKQAFLYKLVDSVIESMKEFYPYLIDKKTLVEQTIKDEEEKFLKTLSKGYDLLENIIKTKNTVSDKDALLLFESYGFPIEQTIEISELSNVTVDVEGFKKLLEQTKQATRNARKDLKAWDKQNELFTKLKVESEFTGWSETSRDNAKVIYMFTDQKQVESITNQEVFVILDKTPFYAEKGGQAADSGIIFNDQMKGFVIDVQQGPTHQNIHRIKVQGTLKVNDLINCRVDEEKRIYTMKNHSGTHMIHYALREVLGTSVMQSGSYNDENGLRMDFTYHRLPTNQELLKAQNLVLEKIKNKIDRQTYFCSLEESVKKHQALAFFTEKYDQIVRVIKFGDFSSELCGGTHVNNTSEIEDFIITGIESKGSGLYRIKCLTSFRAVNEYLNEQFKVYKDQAESIIDKYNQNKDLLKNDQLENIYLQIKNTTINKDNLLVIKNLLDQSKEVNKDYDKKVNDLITANKLLKYKDLTPSLNKDNINEIRLETTDLNIKDLKQLADDLRNKYNDLIVILLSSTNENTFIVVAVSQSLQNKYKAIDIFNNLEGYETKGGGNANLAQGKFVKK